home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Antibodies That Neutralize Multiple Flu Strains

  March, 5 2009 20:08
your information resource in human molecular genetics

Researchers have engineered human antibodies that protect animals against lethal doses of multiple strains of influenza virus. These antibodies, described online in Nature Structural & Molecular Biology, work with a broad array of influenza viral strains, including H5N1 avian flu and the H1N1 1918 Spanish flu.

After illness or vaccination, the body normally produces antibodies to protect itself from a future flu attack, but these antibodies usually neutralize only the same virus strain that infected it.

Wayne Marasco and colleagues selected broadly neutralizing antibodies against an influenza protein called hemagglutinin. Hemagglutinin anchors the virus to the host cells and promotes viral fusion, effectively allowing the virus to invade the cell. The antibodies prevented viral fusion by recognizing a region of hemagglutinin that is not very visible to the immune system and that does not show large variability among strains. In this way the antibodies were able to bind to 8 of the 16 existing types of influenza hemagglutinin tested.

In an accompanying News & Views article, Peter Palese says the work indicates that "a universal immune-based treatment or vaccine may not be out of reach".

Author contacts:

Wayne Marasco (Dana-Farber Cancer Institute, Boston, MA, USA)
E-mail: wayne_marasco@dfci.harvard.edu

Robert Liddington (Burnham Institute for Medical Research, La Jolla, CA, USA)
E-mail: rlidding@burnham.org

Ruben Donis (Centers for Disease Control and Prevention, Atlanta, GA, USA)
E-mail: rvd6@cdc.gov

Jianhua Sui (Dana-Farber Cancer Institute, Boston, MA, USA
E-mail: jianhua_sui@dfci.harvard.edu

Abstract available online.

(C) Nature Structural & Molecular Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.